Research from Public Assistance - Paris Hospitals (AP-HP) in the Area of Antibiotics Published (Cefiderocol Treatment for Severe Infections due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case ...)

MLA

“Research from Public Assistance - Paris Hospitals (AP-HP) in the Area of Antibiotics Published (Cefiderocol Treatment for Severe Infections Due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case ...).” Obesity, Fitness & Wellness Week, June 2023, p. 3711. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.753352384&authtype=sso&custid=ns315887.

APA

Research from Public Assistance - Paris Hospitals (AP-HP) in the Area of Antibiotics Published (Cefiderocol Treatment for Severe Infections due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case ...). (2023, June 24). Obesity, Fitness & Wellness Week, 3711.

Chicago

Obesity, Fitness & Wellness Week. 2023. “Research from Public Assistance - Paris Hospitals (AP-HP) in the Area of Antibiotics Published (Cefiderocol Treatment for Severe Infections Due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case ...),” June 24. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.753352384&authtype=sso&custid=ns315887.